Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT06423651
Eligibility Criteria:
Inclusion Criteria:
* Presence of one of the e following diagnostics according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5): schizophrenia, schizophreniform disorder, delusional disorder, brief psychotic disorder, schizoaffective disorder, and non specified schizophrenia spectrum disorder and other psychotic disorders.
* Be in a stable clinical phase (without psychiatric hospitalization in the last 3 months).
* Have good adherence to pharmacological treatment.
* T-score \< 40 in any cognitive outcome measured by TAVEC, CPT-IP, TMT, Stroop, WSCT, FAS and WAIS (Vocabulary, Digit Forward, Digit Backwards and Digit Symbol Coding.
* Willing to participate in the study expressed by providing signed informed consent.
Exclusion Criteria:
* Presence of traumatic brain lesion, dementia or intellectual discapacity (IQ \<70).
* Positive and Negative Syndrome Scale (PANSS) score \>= 5 in hostility and lack of cooperation and \>= 6 in suspiciousness.
* Presence of an additional diagnosis of severe disorder related to substances.
* Having participated in a CR and/or MCT intervention in the year prior to incorporation into the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
55 Years
Study:
NCT06423651
Study Brief:
Protocol Section:
NCT06423651